Fifth, data related to the following were lacking: features of breast cancer such as the pathology, staging, grading, tumor size, and nodal involvement at diagnosis; estrogen receptor status and other molecular features; administered therapy; response to therapy; and related outcomes of local or distant recurrence. This evidence concerns the gene ESR1 and neoplasm.